The Myeloproliferative Neoplasms (MPN) Advances Day 2019 took place on 15 November, in London, UK. Leading experts came together to present recent advances in understanding the disease biology of MPNs and how they can be treated, providing an opportunity for clinicians to keep abreast of the field.
Key topics from the meeting included essential thrombocythemia (ET), polycythemia vera, myelofibrosis, and atypical MPNs. Presentation topics included clonal hemopoiesis to leukemia, novel therapies for mastocytosis, and what new therapies can offer MPN patients. View e-learning webcasts from all three sessions below.